Trial intelligence / Profile preview

Gabapentin for postoperative pain after endoscopic nasal surgery

IRCT20260423069143N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of gabapentin in postoperative pain (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Aug 2026; status: completed.

02

Drugs

gabapentin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20260423069143N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260423069143N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call